99.4% Predictive Accuracy

Validated to predict toxicology-based Phase I failures with >99% accuracy.

Whole Proteome Context

Screening performed against the full human interactome, not just isolated targets.

Multi-Species Safety

Simultaneous detection of off-target effects across human and microbiome proteomes.

Prevent Phase II Failure

Redirect budget away from toxic assets before they enter the clinic.

Synthyra PreCheck

The essential first-pass filter for any molecule-based product pipeline.

Protect IP Value

Ensure only your most specific, viable binders are patented and progressed.

Identify "AI Mistakes"

Instantly filter hallucinated candidates from generative models.

High-Throughput Scale

Throughput capability to screen billions of interactions in minutes.

$60B Loss Prevention

Directly addressing the industry's massive capital loss on failed trials.